Cranbrook Wealth Management’s Medtronic MDT Stock Holding History

Cranbrook Wealth Management’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$41.4K	Sell	529 -125	-19%	-$10.1K	0.01%	211
2026 Q1	$56.7K	Hold	654	–	–	0.01%	190
2025 Q4	$62.8K	Hold	654	–	–	0.01%	192
2025 Q3	$62.3K	Hold	654	–	–	0.01%	190
2025 Q2	$57K	Sell	654 -29	-4%	-$2.46K	0.01%	190
2025 Q1	$61.4K	Sell	683 -64	-9%	-$5.73K	0.01%	177
2024 Q4	$59.7K	Hold	747	–	–	0.01%	180
2024 Q3	$67.3K	Sell	747 -403	-35%	-$33.9K	0.02%	170
2024 Q2	$90.5K	Buy	+1,150	New	+$94.3K	0.02%	150
2022 Q1	–	Sell	-65	Closed	-$7K	–	363
2021 Q4	$7K	Hold	65	–	–	﹤0.01%	304
2021 Q3	$8K	Buy	+65	New	+$8.41K	﹤0.01%	304
2014 Q1	–	Sell	-65	Closed	–	–	193
2013 Q4	$0	Buy	+65	New	+$3.69K	﹤0.01%	232

Other funds holding MDT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Cranbrook Wealth Management's MDT Position: Q2 2026 in Review

Cranbrook Wealth Management reduced its Medtronic (MDT) stake by 19% in Q2 2026, selling an estimated $10.1K and leaving 529 shares worth $41.4K. The position accounts for 0.01% of the portfolio, ranked #211.

Cranbrook Wealth Management first reported a position in MDT in Q4 2013 and has held it in 12 quarters since. The position peaked at $90.5K in Q2 2024. 2,128 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

Cranbrook Wealth Management held 529 shares of Medtronic worth $41.4K as of Q2 2026.
Cranbrook Wealth Management sold 125 Medtronic shares in Q2 2026, an estimated $10.1K.
Medtronic made up 0.01% of Cranbrook Wealth Management's portfolio in Q2 2026, its #211 holding.
Cranbrook Wealth Management first reported a position in Medtronic in Q4 2013 and has held it in 12 quarters since.
Cranbrook Wealth Management's Medtronic position peaked at $90.5K in Q2 2024.
2,128 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Cranbrook Wealth Management's 13F filing for Q2 2026, filed 6 Aug 2026.